Skip to main content
Clinical Trials/NCT05810012
NCT05810012
Completed
Phase 2

Comparison of Analgesic Efficacy of Ultrasound Guided Pericapsular Nerve Group Block Versus Fascia Iliaca Compartment Block in Patients of Hip Fracture

Pain Medicine Department1 site in 1 country50 target enrollmentApril 1, 2022

Overview

Phase
Phase 2
Intervention
PENG block
Conditions
Post-operative Pain Management
Sponsor
Pain Medicine Department
Enrollment
50
Locations
1
Primary Endpoint
Pain score using Numeric Rating scale
Status
Completed
Last Updated
last year

Overview

Brief Summary

This study was done to evaluate two different interventions for postoperative pain control in patients undergoing hip surgeries. Fifty patients, divided in two equal groups, were included in the study. Patients in Group P were given pericapsular nerve group (PENG) block while those in Group F were given fascia iliaca compartment block (FICB). Pain score, using Numeric Rating scale as a measurement tool, was assessed at one, six, eighteen and twenty fours after the procedure as a primary outcome. Total tramadol consumption in milligrams was recorded as a secondary outcome.

Registry
clinicaltrials.gov
Start Date
April 1, 2022
End Date
October 31, 2022
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Pain Medicine Department
Responsible Party
Principal Investigator
Principal Investigator

Moazzam Ali

Consultant Pain Specialist

Pain Medicine Department

Eligibility Criteria

Inclusion Criteria

  • surgical correction of fracture neck of femur under spinal anaesthesia

Exclusion Criteria

  • allergy to local anaesthetics
  • bleeding disorders
  • morbid obesity with BMI more than 35
  • patients of chronic pain
  • drug addiction
  • psychiatric issues

Arms & Interventions

PENG Block Group

Intervention: PENG block

FICB Group

Intervention: FICB Block

Outcomes

Primary Outcomes

Pain score using Numeric Rating scale

Time Frame: 24 hours

Pain scored assessed after completion of surgery at one, six, eighteen and twenty fours

Secondary Outcomes

  • Total Tramadol consumption(24 hours)

Study Sites (1)

Loading locations...

Similar Trials